SkinHealth Systems (SKIN) Liabilities and Shareholders Equity (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $473.2 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $473.2 million, down 29.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 billion (down 28.39% YoY), and the FY2025 annual result was $499.8 million, down 27.11% from the prior year.
• Liabilities and Shareholders Equity retreated to $473.2 million in Q1 2026 per SKIN's latest filing, from $499.8 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $1.2 billion in Q2 2022 and troughed at $473.2 million in Q1 2026.
• A 5-year average of $825.1 million and a median of $844.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity surged 254.72% in 2022, then declined 29.77% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.0 billion in 2022, then declined by 7.37% to $929.1 million in 2023, then declined by 26.2% to $685.7 million in 2024, then declined by 27.11% to $499.8 million in 2025, then fell by 5.32% to $473.2 million in 2026.
• Business Quant data shows SKIN's Liabilities and Shareholders Equity at $473.2 million in Q1 2026, $499.8 million in Q4 2025, and $503.6 million in Q3 2025.